1204 related articles for article (PubMed ID: 26901377)
21. Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and
Miesel L; Cushion MT; Ashbaugh A; Lopez SR; Ong V
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318018
[TBL] [Abstract][Full Text] [Related]
22. [Changes in invasive aspergillosis and candidiasis epidemiology].
Kibbler C
Med Mal Infect; 2007; 37 Suppl 2():2-4. PubMed ID: 17933657
[TBL] [Abstract][Full Text] [Related]
23. Frequency, diagnosis and management of fungal respiratory infections.
Hayes GE; Denning DW
Curr Opin Pulm Med; 2013 May; 19(3):259-65. PubMed ID: 23411576
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.
Harrison D; Muskett H; Harvey S; Grieve R; Shahin J; Patel K; Sadique Z; Allen E; Dybowski R; Jit M; Edgeworth J; Kibbler C; Barnes R; Soni N; Rowan K
Health Technol Assess; 2013 Feb; 17(3):1-156. PubMed ID: 23369845
[TBL] [Abstract][Full Text] [Related]
25. Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
Koo S; Baden LR; Marty FM
Clin Microbiol Infect; 2012 May; 18(5):E122-7. PubMed ID: 22404638
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
[TBL] [Abstract][Full Text] [Related]
27. The changing face of epidemiology of invasive fungal disease in Europe.
Lass-Flörl C
Mycoses; 2009 May; 52(3):197-205. PubMed ID: 19391253
[TBL] [Abstract][Full Text] [Related]
28. Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options.
Dodds Ashley E; Drew R; Johnson M; Danna R; Dabrowski D; Walker V; Prasad M; Alexander B; Papadopoulos G; Perfect J
Pharmacotherapy; 2012 Oct; 32(10):890-901. PubMed ID: 23033228
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review.
Azim A; Ahmed A
Front Cell Infect Microbiol; 2024; 14():1256158. PubMed ID: 38505289
[TBL] [Abstract][Full Text] [Related]
30. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
31. Antifungal prophylaxis during neutropenia and immunodeficiency.
Lortholary O; Dupont B
Clin Microbiol Rev; 1997 Jul; 10(3):477-504. PubMed ID: 9227863
[TBL] [Abstract][Full Text] [Related]
32. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
[TBL] [Abstract][Full Text] [Related]
33. [Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants].
Quindós G
Rev Iberoam Micol; 2011; 28(3):110-9. PubMed ID: 21700230
[TBL] [Abstract][Full Text] [Related]
34. Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018).
Bretagne S; Sitbon K; Desnos-Ollivier M; Garcia-Hermoso D; Letscher-Bru V; Cassaing S; Millon L; Morio F; Gangneux JP; Hasseine L; Favennec L; Cateau E; Bailly E; Moniot M; Bonhomme J; Desbois-Nogard N; Chouaki T; Paugam A; Bouteille B; Pihet M; Dalle F; Eloy O; Sasso M; Demar M; Mariani-Kurkdjian P; Robert V; Lortholary O; Dromer F;
mBio; 2022 Jun; 13(3):e0092022. PubMed ID: 35499498
[TBL] [Abstract][Full Text] [Related]
35. Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an Intensive Care Unit: a case report.
Saito T; Shime N; Itoh K; Fujita N; Saito Y; Shinozaki M; Shibuya K; Makimura K; Hashimoto S
Infection; 2009 Dec; 37(6):547-50. PubMed ID: 19730788
[TBL] [Abstract][Full Text] [Related]
36. Posaconazole: an extended-spectrum triazole antifungal agent.
Schiller DS; Fung HB
Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
[TBL] [Abstract][Full Text] [Related]
37. The place for itraconazole in treatment.
Maertens J; Boogaerts M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the significance of molecular methods in the diagnosis of invasive fungal infections: comparison with conventional methods].
Susever S; Yeğenoğlu Y
Mikrobiyol Bul; 2011 Apr; 45(2):325-35. PubMed ID: 21644076
[TBL] [Abstract][Full Text] [Related]
39. Micafungin use in children.
Emiroglu M
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
[TBL] [Abstract][Full Text] [Related]
40. Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units.
Shahin J; Allen EJ; Patel K; Muskett H; Harvey SE; Edgeworth J; Kibbler CC; Barnes RA; Biswas S; Soni N; Rowan KM; Harrison DA;
BMC Infect Dis; 2016 Sep; 16(1):480. PubMed ID: 27612566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
